Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry VandenDriessche

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Blood|September 5, 2009
Muscling through AAV immunityThierry VandenDriessche
The Journal of Gene Medicine|July 2, 2005
Gene therapy flexes muscleThierry VandenDriessche
Human Gene Therapy Methods|December 17, 2013
Optimizing delivery and expression of designer nucleases for genome engineeringMarinee K Chuah, Thierry VandenDriessche
Human Gene Therapy|August 11, 2017
Hemophilia Gene Therapy: Ready for Prime Time?Thierry VandenDriessche, Marinee K Chuah
Blood|September 21, 2013
Targeting endothelial cells by gene therapyThierry Vandendriessche, Marinee K Chuah
Science Translational Medicine|July 19, 2013
Vector decoys trick the immune responseThierry VandenDriessche, Marinee K Chuah
The Journal of Gene Medicine|September 18, 2010
Gene therapy strategies for hemophilia: benefits versus risksInge Petrus, Marinee Chuah, Thierry VandenDriessche
Seminars in Thrombosis and Hemostasis|May 1, 2004
Clinical gene transfer studies for hemophilia AMarinee K Chuah, Désiré Collen, Thierry VandenDriessche
Therapeutic Advances in Hematology|November 3, 2025
CRISPR and gene editing technologies for bleeding disordersThierry VandenDriessche, Mathias Janssens, Marinee K Chuah
Human Gene Therapy|September 19, 2017
Transposons: Moving Forward from Preclinical Studies to Clinical TrialsJaitip Tipanee, Thierry VandenDriessche, Marinee K Chuah
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Blood|September 5, 2009
Muscling through AAV immunityThierry VandenDriessche
The Journal of Gene Medicine|July 2, 2005
Gene therapy flexes muscleThierry VandenDriessche
Human Gene Therapy Methods|December 17, 2013
Optimizing delivery and expression of designer nucleases for genome engineeringMarinee K Chuah, Thierry VandenDriessche
Human Gene Therapy|August 11, 2017
Hemophilia Gene Therapy: Ready for Prime Time?Thierry VandenDriessche, Marinee K Chuah
Blood|September 21, 2013
Targeting endothelial cells by gene therapyThierry Vandendriessche, Marinee K Chuah
Science Translational Medicine|July 19, 2013
Vector decoys trick the immune responseThierry VandenDriessche, Marinee K Chuah
The Journal of Gene Medicine|September 18, 2010
Gene therapy strategies for hemophilia: benefits versus risksInge Petrus, Marinee Chuah, Thierry VandenDriessche
Seminars in Thrombosis and Hemostasis|May 1, 2004
Clinical gene transfer studies for hemophilia AMarinee K Chuah, Désiré Collen, Thierry VandenDriessche
Therapeutic Advances in Hematology|November 3, 2025
CRISPR and gene editing technologies for bleeding disordersThierry VandenDriessche, Mathias Janssens, Marinee K Chuah
Human Gene Therapy|September 19, 2017
Transposons: Moving Forward from Preclinical Studies to Clinical TrialsJaitip Tipanee, Thierry VandenDriessche, Marinee K Chuah
Pageof 9